This Article  • Full text  • PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cataracts/ Lens  • Diabetic Retinopathy  • Glaucoma  • Macular Degeneration  • Articles for Residents  • Alert me on articles by topic  Social Bookmarking   What's this?

David B. Rein, PhD; Ping Zhang, PhD; Kathleen E. Wirth, BA; Paul P. Lee, MD, JD; Thomas J. Hoerger, PhD; Nancy McCall, ScD; Ronald Klein, MD, MPH; James M. Tielsch, PhD; Sandeep Vijan, MD, MS; Jinan Saaddine, MD, MPH

Arch Ophthalmol. 2006;124:1754-1760.

Objective  To estimate the societal economic burden and the governmental budgetary impact of the following visual disorders among US adults aged 40 years and older: visual impairment, blindness, refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and primary open-angle glaucoma.

Design  We estimated 3 components of economic burden: direct medical costs, other direct costs, and productivity losses. We used private insurance and Medicare claims data to estimate direct medical costs; epidemiologic evidence from multiple published sources to estimate other direct costs, such as nursing home costs; and data from the Survey of Income and Program Participation to estimate productivity losses. We used budgetary documents and our direct medical and other direct cost estimates to approximate the governmental budgetary impact.

Results  We estimated that the annual total financial burden of major adult visual disorders is $35.4 billion ($16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in productivity losses) and that the annual governmental budgetary impact is $13.7 billion.

Conclusions  Major visual disorders among Americans older than 40 years result in substantial economic costs for the US economy. Well-designed public health programs may have the ability to reduce this burden in the future.

Author Affiliations: RTI International, Research Triangle Park, NC (Drs Rein, Wirth, Hoerger, and McCall); Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, Ga (Drs Zhang and Saaddine); Duke University Center for Health Policy Law and Management, Durham, NC (Dr Lee); University of Wisconsin–Madison, Department of Ophthalmology and Visual Sciences, Madison (Dr Klein); Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Md (Dr Tielsch); University of Michigan, Veterans Affairs Health Services Research, Development Center for Practice Management and Outcomes Research, Ann Arbor (Dr Vijan).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Global Visual Acuity Data in a Time Trade-off Approach to Calculate the Cost Utility of Cataract Surgery
Lansingh and Carter
Arch Ophthalmol 2009;127:1183-1193.
ABSTRACT | FULL TEXT  

Trends in Annual Medicare Expenditures for Glaucoma Surgical Procedures From 1997 to 2006
Schmier et al.
Arch Ophthalmol 2009;127:900-905.
ABSTRACT | FULL TEXT  

High-Rate Internal Pressurization of Human Eyes to Predict Globe Rupture
Bisplinghoff et al.
Arch Ophthalmol 2009;127:520-523.
ABSTRACT | FULL TEXT  

Forecasting Age-Related Macular Degeneration Through the Year 2050: The Potential Impact of New Treatments
Rein et al.
Arch Ophthalmol 2009;127:533-540.
ABSTRACT | FULL TEXT  

Longitudinal Incidence of Adverse Outcomes of Age-Related Macular Degeneration
Wysong et al.
Arch Ophthalmol 2009;127:320-327.
ABSTRACT | FULL TEXT  

Is Universal Vision Care Coverage the Best Way to Get People to See Their Eye Care Providers?
Kymes and Frick
Arch Ophthalmol 2009;127:335-336.
FULL TEXT  

Projection of Diabetic Retinopathy and Other Major Eye Diseases Among People With Diabetes Mellitus: United States, 2005-2050
Saaddine et al.
Arch Ophthalmol 2008;126:1740-1747.
ABSTRACT | FULL TEXT  

Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons
Shea et al.
Arch Ophthalmol 2008;126:1748-1754.
ABSTRACT | FULL TEXT  

Does Functional Vision Behave Differently in Low-Vision Patients with Diabetic Retinopathy?--A Case-Matched Study
Ahmadian and Massof
IOVS 2008;49:4051-4057.
ABSTRACT | FULL TEXT  

Prevalence of Refractive Error in the United States, 1999-2004
Vitale et al.
Arch Ophthalmol 2008;126:1111-1119.
ABSTRACT | FULL TEXT  

Health Insurance Coverage and Use of Eye Care Services
Zhang et al.
Arch Ophthalmol 2008;126:1121-1126.
ABSTRACT | FULL TEXT  

Impact of Vision Loss on Costs and Outcomes in Medicare Beneficiaries With Glaucoma
Bramley et al.
Arch Ophthalmol 2008;126:849-856.
ABSTRACT | FULL TEXT  

Prevalence of Major Eye Diseases Among US Civil War Veterans, 1890-1910
Sloan et al.
Arch Ophthalmol 2008;126:246-250.
ABSTRACT | FULL TEXT  

Poverty and blindness in Pakistan: results from the Pakistan national blindness and visual impairment survey
Gilbert et al.
BMJ 2008;336:29-32.
ABSTRACT | FULL TEXT  

VISION LOSS AND AGING: FROM DISCONNECT TO CROSSROADS IN THE FIELD?
Stuen
Gerontologist 2007;47:858-862.
FULL TEXT